COMPARATIVE ANALYSIS IMMUNOTROPIC EFFECTS IN VITRO DERINAT AND SYNTHETIC TLR9 AGONIST ON RECEPTOR FUNCTION OF NEUTROPHILIC GRANULOCYTES AND MONOCYTES IN NORMAL AND INFECTIOUS PROCE... by T. V. Rusinova, G. A. Chudilova, N. V. Kolesnikova

Subjects: Get full text

Phagocytosis‐dependent activation of a TLR9–BTK–calcineurin–NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus by Susanne Herbst, Anand Shah, Maria Mazon Moya, Vanessa Marzola, Barbara Jensen, Anna Reed, Mark A Birrell, Shinobu Saijo, Serge Mostowy, Sunil Shaunak, Darius Armstrong‐James

Subjects: Get full text

Glycyrrhizin Interacts with TLR4 and TLR9 to Resolve <i>P. aeruginosa</i> Keratitis by Mallika Somayajulu, Sharon A. McClellan, Shukkur Muhammed Farooq, Ahalya Pitchaikannu, Shunbin Xu, Linda Hazlett

Subjects: Get full text

Immunocytochemical characteristic of the endometrial mucosa HIV-infected women by Irina N. Vorobtsova, Natalya I. Tapilskaya, Elena S. Orlova, Nikolay N. Rukhlyada, Sergei N. Proshin, Ruslan I. Glushakov

Subjects: Get full text

Expresión de moléculas HLA-DR, coestimuladoras y TLR9 en células presentadoras de antígenos circulantes de pacientes con lupus eritematoso sistémico (LES) by Gloria Vásquez, Luis García, Luis Ramírez, Oscar Uribe, Liliana Arango, Soraya Zorro

Subjects: Get full text

Association of TLR7 and TLR9 genes polymorphisms in Egyptian patients with systemic lupus erythematosus by Marwa M. Azab, Fatma M. Mostafa, Mayada Khalil, Mona Salama, Ali A. Abdelrahman, Aya A. Ali

Subjects: Get full text

Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Adv... by Marcelo V. Negrao, MD, Vassiliki A. Papadimitrakopoulou, MD, Andrew C. Price, MD, PhD, Alda L. Tam, MD, MBA, Muhammad Furqan, MD, Sandeep T. Laroia, MD, Erminia Massarelli, MS, MD, PhD, Jose Pacheco, MD, John V. Heymach, MD, PhD, Anne S. Tsao, MD, Gary V. Walker, MD, Lalit Vora, MD, David Mauro, MD, PhD, Heather Kelley, MA, James E. Wooldridge, MD, Arthur M. Krieg, MD, Jiaxin Niu, MD

Subjects: Get full text

Toll-like Receptor 9 in Breast Cancer by Katri eSelander, Katri eSelander, Jouko eSandholm

Subjects: Get full text

TACI Isoforms Regulate Ligand Binding and Receptor Function by Yolanda Garcia-Carmona, Adrian T. Ting, Lin Radigan, Sai Krishna Athuluri Divakar, Jose Chavez, Eric Meffre, Andrea Cerutti, Andrea Cerutti, Andrea Cerutti, Charlotte Cunningham-Rundles, Charlotte Cunningham-Rundles

Subjects: Get full text

Interaction of CpG-Oligodeoxynucleotides with Toll Like Receptor 9 Induces Apoptosis and Modulates Metaloproteinase-2 Activity in Human Intestinal Epithelium by Mohammad Reza Khorramizadeh, Shahnaz Hosseinzadeh, Farnaz Safavifar, Farshid Saadat, Nastaran Aalizadeh, Reza Falak, Zohre Jadali, Mohammad Pezeshki

Subjects: Get full text

Expression of TLR9 and NF-κB in condyloma acuminatum by Guangwen YIN, Jiayin LIU, Jiadi YAN, Mengmeng GENG, Yidan ZHANG

Subjects: Get full text

Morphofunctional markers of the efficiency stimulated by the pool proliferation of the nasal mucosa cells in patients with polyposis rinosinusitis by L.S. Bakulina, D.Yu. Bugrimov, O.V. Lidokhova, O.V. Kashaeva

Subjects:

Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma by Sare Hajiabadi, Soodeh Alidadi, Zohreh Montakhab Farahi, Mohammad M. Ghahramani Seno, Hamidreza Farzin, Alireza Haghparast

Subjects: Get full text

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine by Li Q, Ren J, Liu W, Jiang G, Hu R

Subjects: Get full text

A Multi‐Functional Nanoadjuvant Coupling Manganese with Toll‐Like 9 Agonist Stimulates Potent Innate and Adaptive Anti‐Tumor Immunity by Zhongjie Liu, Shu Li, Yang Xiao, Xiaoyang Liu, Bin Zhang, Qin Zeng, Qiang Ao, Xingdong Zhang

Subjects: Get full text

Pathomorphological Markers of Overcoming Radioresistance in the Treatment of Cervical Cancer by Pavel Yu. Andreev, Daniil Yu. Bugrimov, Andrey A. Filin, Olga V. Kashaeva, Natalya V. Korotkikh, Andrey A. Klimovich

Subjects: Get full text

Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction by Max Lenz, Attila Kiss, Patrick Haider, Manuel Salzmann, Mira Brekalo, Konstantin A. Krychtiuk, Ouafa Hamza, Kurt Huber, Christian Hengstenberg, Bruno K. Podesser, Johann Wojta, Philipp J. Hohensinner, Walter S. Speidl

Subjects: Get full text

Giardia duodenalis Induces Proinflammatory Cytokine Production in Mouse Macrophages via TLR9-Mediated p38 and ERK Signaling Pathways by Xudong Pu, Xin Li, Lili Cao, Lili Cao, Kaiming Yue, Panpan Zhao, Xiaocen Wang, Jianhua Li, Xichen Zhang, Nan Zhang, Zhiteng Zhao, Min Liang, Pengtao Gong

Subjects: Get full text

The regulatory capacity of B cells directs the aggressiveness of CLL by Audrey Mohr, Marie Cumin, Cristina Bagacean, Pierre Pochard, Christelle Le Dantec, Sophie Hillion, Yves Renaudineau, Christian Berthou, Adrian Tempescul, Hussam Saad, Jacques-Olivier Pers, Anne Bordron, Christophe Jamin

Subjects: Get full text

The role of Toll-like receptors (TLRs) in virus-related cancers: a mini review by Dworzanska Anna, Polz-Dacewicz Małgorzata

Subjects: “…tlr9…”
Get full text